Breaking News Instant updates and real-time market news.

TGT

Target

$110.86

0.27 (0.24%)

06:37
11/20/19
11/20
06:37
11/20/19
06:37

Target raises FY19 adj EPS view to $6.25-$6.45 from $5.90-$6.20, consensus $6.18

  • 20

    Nov

TGT Target
$110.86

0.27 (0.24%)

10/25/19
10/25/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Target (TGT) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Kate McShane saying with the stock up 4% over the past month and 67% year-to-date, investor expectations already seem to be pricing in more of Target's progress. 2. Kinder Morgan (KMI) downgraded to Neutral from Buy at Goldman Sachs. 3. Avis Budget (CAR) downgraded to Hold from Buy at Deutsche Bank. 4. Vocera (VCRA) downgraded to Neutral from Outperform at Baird, to Neutral from Overweight at Cantor Fitzgerald, and to Hold from Buy at Craig-Hallum. 5. Pros Holdings (PRO) downgraded to Neutral from Overweight at JPMorgan with analyst Jackson Ader saying he has "mixed feelings" following last night's Q3 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/07/19
CLVD
11/07/19
NO CHANGE
CLVD
Neutral
Target sales growth appeared to slow in back half of Q3, says Cleveland Research
Cleveland Research analyst said his work indicates that sales momentum appeared to slow a bit more than he was expecting at Target in the second half of the third quarter following a strong start. Based on his checks, he has lowered his Q3 comp store sales growth estimate to up 3.8% from 4.0%, though he note this is still above both consensus and guidance. The analyst, who also trimmed his Q3 EPS estimate by a penny to $1.24, keeps a Neutral rating on Target shares.
11/07/19
NOMU
11/07/19
INITIATION
Target $123
NOMU
Buy
Target initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Michael Baker initiated coverage of Target with a Buy rating and $123 price target. The analyst sees the company as an "impressive turnaround candidate" operating in a favorable macro backdrop. Baker adds that Target's investment phase levers are gaining traction, which should drive sustained comp and market share gains.
11/11/19
KEYB
11/11/19
NO CHANGE
Target $130
KEYB
Overweight
Target price target raised to $130 from $120 at KeyBanc
KeyBanc analyst Edward Yruma raised his price target for Target to $130 from $120 and keeps an Overweight rating, telling investors in a research note that he believes Target is uniquely positioned to capture share from store closures in the mid-tier department. Share gains in the apparel and home furnishings categories should give Target continued margin expansion opportunity, Yruma adds.

TODAY'S FREE FLY STORIES

BIDU

Baidu

$115.82

-1.04 (-0.89%)

, TCEHY

Tencent

$0.00

(0.00%)

13:36
12/06/19
12/06
13:36
12/06/19
13:36
Hot Stocks
Baidu reports filing total of 5,712 AI-related patent applications »

Baidu (BIDU) announced in…

BIDU

Baidu

$115.82

-1.04 (-0.89%)

TCEHY

Tencent

$0.00

(0.00%)

MSFT

Microsoft

$151.36

1.44 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/06/19
12/06
13:17
12/06/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/06/19
12/06
13:16
12/06/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,749.41

8.82 (0.51%)

13:08
12/06/19
12/06
13:08
12/06/19
13:08
Periodicals
Amazon says U.K. soccer streams brought record Prime sign-ups, Guardian says »

Amazon has said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$22.28

0.14 (0.63%)

13:05
12/06/19
12/06
13:05
12/06/19
13:05
Hot Stocks
Baker Hughes reports U.S. rig count down 3 to 799 rigs »

Baker Hughes reports the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LDOS

Leidos

$89.77

-0.14 (-0.16%)

, PSN

Parsons

$40.51

0.66 (1.66%)

13:00
12/06/19
12/06
13:00
12/06/19
13:00
Recommendations
Leidos, Parsons analyst commentary  »

Wells says investors…

LDOS

Leidos

$89.77

-0.14 (-0.16%)

PSN

Parsons

$40.51

0.66 (1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SPY

SPDR S&P 500 ETF Trust

$315.21

3.17 (1.02%)

, VOO

Vanguard S&P 500 ETF

$289.57

2.94 (1.03%)

12:58
12/06/19
12/06
12:58
12/06/19
12:58
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week flows to the…

SPY

SPDR S&P 500 ETF Trust

$315.21

3.17 (1.02%)

VOO

Vanguard S&P 500 ETF

$289.57

2.94 (1.03%)

XLY

Consumer Discretionary Sector SPDR

$121.97

1.19 (0.99%)

XLI

Industrial Select Sector SPDR

$81.21

1.08 (1.35%)

IEF

iShares 7-10 Year Treasury Bond ETF

$110.99

-0.34 (-0.31%)

GLD

SPDR Gold Shares

$137.61

-1.4 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$234.00

0.56 (0.24%)

, JNJ

Johnson & Johnson

$141.00

1.43 (1.02%)

12:53
12/06/19
12/06
12:53
12/06/19
12:53
Hot Stocks
FDA approves Amgen's Avsola »

The U.S. Food and Drug…

AMGN

Amgen

$234.00

0.56 (0.24%)

JNJ

Johnson & Johnson

$141.00

1.43 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 09

    Dec

  • 21

    Jan

SYPR

Sypris Solutions

$0.82

(0.00%)

, UTX

United Technologies

$147.18

1.87 (1.29%)

12:52
12/06/19
12/06
12:52
12/06/19
12:52
Hot Stocks
Sypris subsidiary wins contracts with United Technologies' Collins Aerospace »

Sypris Electronics, a…

SYPR

Sypris Solutions

$0.82

(0.00%)

UTX

United Technologies

$147.18

1.87 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

LDOS

Leidos

$89.47

-0.44 (-0.49%)

12:49
12/06/19
12/06
12:49
12/06/19
12:49
Hot Stocks
Leidos among team awarded DOE contract for Hanford site services »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMU

Immunomedics

$20.38

1.86 (10.04%)

12:45
12/06/19
12/06
12:45
12/06/19
12:45
Options
Immunomedics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

12:45
12/06/19
12/06
12:45
12/06/19
12:45
General news
Breaking General news story  »

Week of 12/6 Baker-Hughes…

12:45
12/06/19
12/06
12:45
12/06/19
12:45
General news
Breaking General news story  »

Week of 12/6 Baker-Hughes…

12:40
12/06/19
12/06
12:40
12/06/19
12:40
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

12:40
12/06/19
12/06
12:40
12/06/19
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

12:30
12/06/19
12/06
12:30
12/06/19
12:30
General news
Treasury's $25 B 2-year FRN reopening stopped at 0.245% »

Treasury's $25 B…

PIR

Pier 1 Imports

$7.70

-0.27 (-3.39%)

12:22
12/06/19
12/06
12:22
12/06/19
12:22
Periodicals
Pier 1 hired Guggenheim amid concerns over debt, Debtwire reports »

Pier 1 Imports has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLA

Medallia

$29.11

-0.68 (-2.28%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Recommendations
Medallia analyst commentary  »

Oppenheimer says would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

PIR

Pier 1 Imports

$7.92

-0.05 (-0.63%)

12:19
12/06/19
12/06
12:19
12/06/19
12:19
Periodicals
Breaking Periodicals news story on Pier 1 Imports »

Pier 1 hired financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/06/19
12/06
12:17
12/06/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/06/19
12/06
12:16
12/06/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

, XLRN

Acceleron

$48.58

-0.08 (-0.16%)

12:08
12/06/19
12/06
12:08
12/06/19
12:08
Hot Stocks
Bristol-Myers, Acceleron: FDA says Reblozyl will not be reviewed at ODAC meeting »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$60.70

1.195 (2.01%)

XLRN

Acceleron

$48.58

-0.08 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 11

    Dec

  • 04

    Apr

MNTA

Momenta

$17.53

0.68 (4.04%)

12:04
12/06/19
12/06
12:04
12/06/19
12:04
Hot Stocks
Momenta granted orphan status for hemolytic anemia treatment »

The FDA granted Momenta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

EA

Electronic Arts

$102.74

0.66 (0.65%)

, ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

12:03
12/06/19
12/06
12:03
12/06/19
12:03
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

EA

Electronic Arts

$102.74

0.66 (0.65%)

ATVI

Activision Blizzard

$55.08

0.09 (0.16%)

GME

GameStop

$6.46

0.1 (1.57%)

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$123.21

-0.69 (-0.56%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 13

    Dec

PRVL

Prevail Therapeutics

$14.02

-0.03 (-0.21%)

12:02
12/06/19
12/06
12:02
12/06/19
12:02
Hot Stocks
Prevail Therapeutics granted orphan status for dementia treatment »

The FDA granted Prevail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.